CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer.
Xiaoguang QiChunyan QiTao WuYi HuPublished in: Technology in cancer research & treatment (2021)
CSF1 R and HCST might be novel predictive markers for immunotherapy in NSCLC.